Torsdag 9 Oktober | 02:46:20 Europe / Stockholm

Prenumeration

2025-10-02 19:34:00

Redeye retains its SEK394 Base Case in Lime, leaving notable upside potential given the recent soft share price performance. We believe the risk/reward has improved relative to in our Q2 Update, not because we expect a superb Q3, but due to a positive long-term view.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/